10 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Medications - Vaughan Williams ... - Sodium Channel ... agents - Potassium Channel ... agents - Calcium Channels ... #pharmacology #
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
1 - Sodium Channel ... Block fast Na+ channels ... 3 - Potassium Channel ... 4 - Calcium Channel ... #Pharmacology #
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Vaughan Williams ... inotropy) ACCP Cardiology ... Antiarrhythmics #Pharmacology ... pathophysiology #phases #cardiology
Antiarrhythmics - Vaughan Williams Classification
Class I (Ia, Ib, Ic) - Na+ Channel Blockade
 • Slows depolarization
Antiarrhythmics - Vaughan Williams ... Ib, Ic) - Na+ Channel ... III - K+ Channel ... IV - Ca2+ Channel ... #cardiology #pharmacology
Membrane Actions of Antiarrhythmic Drugs

#Membrane #Channels #Actions #Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table
Antiarrhythmic Drugs ... #Membrane #Channels ... Antiarrhythmic #Drugs ... #Medications #Pharmacology ... #Cardiology #Table
Drugs affecting the cardiac action potential. The sharp rise in voltage ("0") corresponds to the influx
Drugs affecting ... to the sodium-channel ... voltage-sensitive calcium channels ... #Pathophys #Pharmacology ... #Classes #Effect
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Antiarrhythmics - Sodium Channel ... Antiarrhythmics #Sodium #Channel ... #Na #cardiology ... #pharmacology # ... table #comparison
Class III Antiarrhythmics - Potassium Channel Blockers - Indications and Side Effects
Amiodarone
 • Suppression of VT
- Potassium Channel ... a-flutter (when other drugs ... Antiarrhythmics #Potassium #Channel ... #Blockers #pharmacology ... #cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug ... tachycardia Calcium Channel ... potential arrhythmias Class ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Class: Selective ... Dosing: 250 mcg tablet ... have been a few changes ... #Indications #Pharmacology